Cross-national comparative study of orphan drug policies in Saudi Arabia, the United States, and the European Union

BACKGROUND: Rare diseases are chronic, serious, and life-threatening conditions that have not received sufficient attention from drug developers due to their rarity. Policies have been implemented to encourage research and incentivize the development of orphan drugs. However, the implementation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Balkhi, Bander, Almuaither, Asma, Alqahtani, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458326/
https://www.ncbi.nlm.nih.gov/pubmed/37638213
http://dx.doi.org/10.1016/j.jsps.2023.101738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458326/
https://www.ncbi.nlm.nih.gov/pubmed/37638213
http://dx.doi.org/10.1016/j.jsps.2023.101738

Ejemplares similares